SeekingAlpha · Jul 31, 2026
Beta Bionics, Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-07-31. The following slide deck was published by Beta Bionics, Inc.
NASDAQ · BBNX
Beta Bionics, Inc.
Healthcare · Medical - Equipment & Services
$19.02
Up+$1.46 (+8.31%)
Updated Aug 19, 2026, 8:31 AM
SID Score
5.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.29B
- P/E ratio
- -16.44
- Dividend yield
- 0.00%
- 52-week range
- $8.80 – $32.71
- Volume
- 1.98M
- Avg. volume
- 804.67K
Price performance
BBNX price history
1M range · 21 trading sessions · Daily adjusted prices
BBNX closed at $19.02 after 21 trading sessions, up 7.95% for the selected period.
- Last close
- $19.02
- Period change
- +7.95%
- Period low
- $12.83
- Period high
- $19.02
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 18, 2026 | $17.56 | $19.08 | $17.50 | $19.02 | 1.98M |
| Aug 17, 2026 | $17.31 | $17.67 | $16.99 | $17.56 | 1.27M |
| Aug 14, 2026 | $18.12 | $18.15 | $17.49 | $17.57 | 935.92K |
| Aug 13, 2026 | $17.33 | $18.325 | $17.04 | $18.08 | 1.5M |
| Aug 12, 2026 | $17.52 | $17.52 | $16.76 | $17.33 | 637.9K |
| Aug 11, 2026 | $16.55 | $17.64 | $16.15 | $17.62 | 613.92K |
| Aug 10, 2026 | $15.66 | $16.86 | $15.641 | $16.40 | 1.32M |
| Aug 7, 2026 | $14.18 | $16.575 | $14.067 | $15.90 | 1.27M |
| Aug 6, 2026 | $13.72 | $14.23 | $13.615 | $14.11 | 590.2K |
| Aug 5, 2026 | $14.59 | $14.68 | $13.698 | $13.91 | 897.08K |
| Aug 4, 2026 | $13.35 | $14.58 | $13.33 | $14.57 | 3.34M |
| Aug 3, 2026 | $12.83 | $13.91 | $12.73 | $13.35 | 2.82M |
| Jul 31, 2026 | $13.99 | $14.283 | $12.79 | $12.83 | 2M |
| Jul 30, 2026 | $15.97 | $16.44 | $13.55 | $14.27 | 3.2M |
| Jul 29, 2026 | $15.65 | $15.96 | $14.96 | $15.17 | 1.67M |
| Jul 28, 2026 | $16.29 | $16.37 | $15.59 | $15.80 | 660.16K |
| Jul 27, 2026 | $16.30 | $16.32 | $15.495 | $15.99 | 850.68K |
| Jul 24, 2026 | $16.37 | $16.37 | $15.73 | $15.85 | 558.67K |
| Jul 23, 2026 | $15.752 | $16.58 | $15.53 | $16.13 | 1.33M |
| Jul 22, 2026 | $17.44 | $17.8144 | $16.28 | $16.31 | 1.39M |
| Jul 21, 2026 | $17.56 | $18.20 | $17.11 | $17.62 | 1.1M |
Latest BBNX news
The latest Smart Investors Daily articles mentioning BBNX.
Stock researchCompany · Overview
BBNX research
Overview
Company profile and research snapshot.
Company profile
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $31.00
- Implied upside
- —
- Analysts
- 16
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 15, 2026 | Goldman Sachs | Buy | — |
| Jul 13, 2026 | Truist Securities | Buy | — |
| May 27, 2026 | Goldman Sachs | Buy | — |
| May 18, 2026 | B of A Securities | Neutral | — |
| Apr 22, 2026 | Leerink Partners | Outperform | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Jul 30, 2026
Beta Bionics, Inc. (BBNX) Q2 2026 Earnings Call Transcript
Beta Bionics, Inc. (BBNX) Q2 2026 Earnings Call July 29, 2026 4:30 PM EDTCompany ParticipantsBlake Beber - Head of Investor RelationsSean Saint - President,...
ChartMill · Jul 29, 2026
Beta Bionics (NASDAQ:BBNX) Q2: EPS Beat and Margin Progress Lift Shares 3% After Hours
Beta Bionics Q2 revenue of $32M in line, EPS beat at -$0.53, stock up 3% after-hours. Gross margin expands, guidance reaffirmed.
Benzinga · Jul 29, 2026
Beta Bionics Affirms FY2026 Sales Guidance of $131.000M-$136.000M vs $133.305M Est
Beta Bionics (NASDAQ:BBNX) affirms FY2026 sales outlook from $131.000 million-$136.000 million to $131.000 million-$136.000 million vs $133.305 million estimate.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
